NewAmsterdam Pharma Company NV Ordinary Shares
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $29,111 | $2,127 | $1,298 | $1,594 |
Gross Profit | 29,111 | 2,109 | 1,298 | 1,594 |
EBITDA | -23,840 | -49,061 | -54,574 | -44,290 |
EBIT | -23,868 | -49,078 | -54,587 | -44,295 |
Net Income | -16,647 | -36,413 | -86,893 | -42,538 |
Net Change In Cash | 29,111 | 2,127 | 1,298 | 1,594 |
Free Cash Flow | -12,577 | -50,492 | -51,165 | -32,497 |
Cash | 422,729 | 401,333 | 414,927 | 309,366 |
Basic Shares | 94,754 | 94,711 | 82,160 | 82,477 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $12,762 | $95,905 | $0 | $0 |
Gross Profit | 12,762 | 95,905 | -14 | |
EBITDA | -176,861 | -3,313 | -30,726 | -5,428 |
EBIT | -176,910 | -3,321 | -30,730 | -5,429 |
Net Income | -176,937 | -21,137 | -36,712 | -5,749 |
Net Change In Cash | 12,762 | 95,905 | 0 | 0 |
Free Cash Flow | -141,242 | 7,959 | -25,184 | -5,983 |
Cash | 340,450 | 438,522 | 53,092 | 7,861 |
Basic Shares | 82,161 | 18,966 | 17,751 | 17,751 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.18 |
2024-06-30 | -$0.41 |
2024-03-31 | -$1.06 |
2023-12-31 | -$0.54 |
